Efficacy Phase IV Dropout Rate Source Data Verification Protocol Investigator Meeting Follow- up Visit Good Clinical Practice (GCP) Pilot Study Endpoint Trial Monitor Data Management Adverse Event Data Safety Monitoring Board (DSMB) Protocol Deviation Clinical Research Coordinator Phase III Institutional Review Board (IRB) Parallel Study Informed Consent Clinical Endpoint Control Group Clinical Study Report (CSR) Intervention Data Lock Phase I Adaptive Design Case Report Form (CRF) Trial Registry Double- Blind Study Eligibility Criteria Blinding Phase II Safety Profile Audit Trail Statistical Analysis Plan (SAP) Regulatory Authority Open- Label Trial Screening Visit Randomization Surrogate Endpoint Recruitment Target Principal Investigator Standard Operating Procedure (SOP) Crossover Study Multicenter Trial Sponsor Ethics Committee Patient Recruitment Placebo Efficacy Phase IV Dropout Rate Source Data Verification Protocol Investigator Meeting Follow- up Visit Good Clinical Practice (GCP) Pilot Study Endpoint Trial Monitor Data Management Adverse Event Data Safety Monitoring Board (DSMB) Protocol Deviation Clinical Research Coordinator Phase III Institutional Review Board (IRB) Parallel Study Informed Consent Clinical Endpoint Control Group Clinical Study Report (CSR) Intervention Data Lock Phase I Adaptive Design Case Report Form (CRF) Trial Registry Double- Blind Study Eligibility Criteria Blinding Phase II Safety Profile Audit Trail Statistical Analysis Plan (SAP) Regulatory Authority Open- Label Trial Screening Visit Randomization Surrogate Endpoint Recruitment Target Principal Investigator Standard Operating Procedure (SOP) Crossover Study Multicenter Trial Sponsor Ethics Committee Patient Recruitment Placebo
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Efficacy
Phase IV
Dropout Rate
Source Data Verification
Protocol
Investigator Meeting
Follow-up Visit
Good Clinical Practice (GCP)
Pilot Study
Endpoint
Trial Monitor
Data Management
Adverse Event
Data Safety Monitoring Board (DSMB)
Protocol Deviation
Clinical Research Coordinator
Phase III
Institutional Review Board (IRB)
Parallel Study
Informed Consent
Clinical Endpoint
Control Group
Clinical Study Report (CSR)
Intervention
Data Lock
Phase I
Adaptive Design
Case Report Form (CRF)
Trial Registry
Double-Blind Study
Eligibility Criteria
Blinding
Phase II
Safety Profile
Audit Trail
Statistical Analysis Plan (SAP)
Regulatory Authority
Open-Label Trial
Screening Visit
Randomization
Surrogate Endpoint
Recruitment Target
Principal Investigator
Standard Operating Procedure (SOP)
Crossover Study
Multicenter Trial
Sponsor
Ethics Committee
Patient Recruitment
Placebo